Endocare Gains Clearance For Benign Breast Tumor Therapy; Malignant Next
This article was originally published in The Gray Sheet
Executive Summary
Endocare will follow up its FDA 510(k) clearance of the Visica minimally invasive cryoablation system for benign breast tumors with a submission for malignant tumors.